United States · FDA National Drug Code directory
DOXIL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0338-0067_15bd5c62-3eb4-464f-b446-76ab04fa1ab4
- Product NDC
- 0338-0067
- Form
- INJECTION, SUSPENSION, LIPOSOMAL
- Composition / generic term
- doxorubicin hydrochloride
- Labeler
- Baxter Healthcare Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190813
- Source listing expiry
- 20271231
Source-listed ingredients
- DOXORUBICIN HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (0338-0067-01) / 25 mL in 1 VIAL, SINGLE-USE · 0338-0067-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →